Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABX-1431 titration in peripheral neuropathic pain
NCT03447756Phase 1Completed
- Sponsor
- Abide Therapeutics
- Start
- Oct 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Peripheral neuropathic pain comparing ABX-1431 with Placebo (2 arms). Primary endpoint: Identify a titration regimen of ABX-1431 at 28 days. Started Oct 2017; status: completed.
02
Drugs
ABX-1431
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT03447756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03447756.